AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $385,616 | -37.0% | 8,385 | -21.3% | 0.00% | 0.0% |
| Q2 2023 | $612,182 | +836.1% | 10,656 | +511.0% | 0.00% | – |
| Q1 2023 | $65,399 | +39.1% | 1,744 | +2.5% | 0.00% | – |
| Q4 2022 | $47,000 | -6.0% | 1,702 | -5.5% | 0.00% | – |
| Q3 2022 | $50,000 | -61.2% | 1,801 | -51.4% | 0.00% | – |
| Q2 2022 | $129,000 | -88.3% | 3,708 | -87.6% | 0.00% | -100.0% |
| Q1 2022 | $1,103,000 | +1942.6% | 29,894 | +1193.6% | 0.00% | – |
| Q4 2021 | $54,000 | +390.9% | 2,311 | +314.2% | 0.00% | – |
| Q3 2021 | $11,000 | -31.2% | 558 | -29.7% | 0.00% | – |
| Q2 2021 | $16,000 | +1500.0% | 794 | +1664.4% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 45 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -90.0% | 45 | -90.8% | 0.00% | – |
| Q3 2020 | $10,000 | -28.6% | 490 | -23.7% | 0.00% | – |
| Q2 2020 | $14,000 | -12.5% | 642 | -40.3% | 0.00% | – |
| Q1 2020 | $16,000 | – | 1,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRIESS ASSOCIATES LLC | 97,760 | $3,401,000 | 5.68% |
| Nantahala Capital Management | 1,000,000 | $34,790,000 | 1.74% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 341,294 | $11,874,000 | 1.52% |
| Portolan Capital Management | 274,889 | $9,563,000 | 0.96% |
| Quantedge Capital Pte Ltd | 121,500 | $4,227,000 | 0.85% |
| SHAKER INVESTMENTS LLC/OH | 37,117 | $1,291,000 | 0.82% |
| GLOBEFLEX CAPITAL L P | 72,253 | $2,514,000 | 0.61% |
| EAM Investors, LLC | 68,855 | $2,395,000 | 0.58% |
| Hillsdale Investment Management Inc. | 197,738 | $6,879,000 | 0.55% |
| Capital Impact Advisors, LLC | 13,835 | $481,000 | 0.44% |